featured Products
Myopia, also known as short-sightedness, is becoming a serious problem in more and more countries. In urban areas of Asia, almost 90% of young people develop myopia before the age of 20 – a trend that continues worldwide.
Studies predict that, by the year 2050, nearly 50 percent of the world's population could be shortsighted. In a worst-case scenario, early myopia can lead to the emergence of progressive myopia, a severe form of short-sightedness. This increases the risk of other eye problems, such as damage to the retina or even blindness.
Development of Myopia in children
MiSight
Cooper Vision MISIGHT® 1 day is the world’s first soft daily disposable contact lens proven to significantly slow the progression of myopia in children.
​
The Myopia Management System is a holistic approach to minimising the progression of myopia by combining MiSight contact lenses with ActivControl™ Technology and strategies for better eye health.
​
Winner: 'Contact Lens Product of the Year’ at the prestigious 2018 Optician Awards.
​
Winner: ‘Best of What’s New Award’ at the 2020 Popular Science, in the health category.
Myocare
ZEISS MyoCare is the latest myopia management lens from ZEISS. It is also the first age-related myopia management lens solution. Backed by ZEISS innovation and more than a decade of experience in developing lenses aimed to manage myopia progression, Myocare features C.A.R.E.® technology (Cylindrical Annular Refractive Elements). C.A.R.E.® :
​
-
aims to deliver a `stop signal' to slow down progression of axial elongation;
-
consists of alternating defocus and correction zones in a ring-like pattern on the front surface, expanding towards the periphery of the lens;
-
aims to remove the `growth signal';
-
has back surface which delivers the refractive correction and intended myopic defocus of the patient for all gaze directions.
​
Miyosmart
HOYA's revolutionary spectacle lens based on patented Defocus Incorporated Multiple Segments (D.I.M.S.) Technology was developed in cooperation with The Hong Kong Polytechnic University in 2014.
​
With the exclusive non-invasive D.I.M.S. Technology, the lens corrects the visual defect on its entire surface and has a ring shaped treatment area to slow down myopia progression. The alternation of the focus area and defocus area provides clear vision and manages myopia simultaneously.
Stellest
Essilor® Stellest™ lens is one of the newest generation of myopia-controlling spectacle lenses, appearing to have efficacy to slow myopia progression in children at least as good as the current 'best' interventions of orthokeratology, dual-focus soft contact lenses, and 0.05% atropine.
Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.
Using H.A.L.T. (Highly Aspherical Lenslet Target) technology, Stellest™ lenses create a signal that acts as a shield to slow down myopia progression.
​
​
